Please provide your email address to receive an email when new articles are posted on . Adults with differentiated thyroid cancer using a GLP-1 had similar risk for recurrence or progression as those ...

GLP-1RAs reduced CRC risk by 35.7% compared to aspirin, with greater reductions in high-risk patients and younger individuals. GLP-1RAs showed a favorable safety profile, with lower rates of ...

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...

Please provide your email address to receive an email when new articles are posted on . A narrative review found that GLP-1 receptor agonists may significantly lower risks for ocular hypertension and ...

Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist. The glucagon-like peptide-1 (GLP-1) class has transformed ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now ...

Certain dietary supplements like protein powder, calcium, and fiber may enhance GLP-1 secretion, which plays a role in insulin production and appetite regulation. While these supplements can be more ...

Weight loss drugs like GLP-1s are rapidly reshaping how Americans think about appetite, health and food – forcing CPG brands to reconsider everything from formulation to front-of-pack messaging.

If you’re taking a GLP-1 medication for weight loss, you may have questions about managing side effects and whether to take nutritional supplements to support your health. As a pharmacist, I’m often ...

Users of GLP-1 weight-loss drugs have the potential to transform the food industry entirely. Eating habits have changed, with smaller portions, lower levels of fat and sugar, and an abundance of ...

In a little over a year, GLP-1 weight-loss drugs have transformed the food sector. Where once they were confined to treatment for diabetes, now around 12% of the US population (by some estimates) uses ...